- Home
- NHI vs ACLX Comparison
NHI vs ACLX Comparison
Compare NHI & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHI
- ACLX
- Stock Information
- Founded
- NHI 1991
- ACLX 2015
- Country
- NHI United States
- ACLX United States
- Employees
- NHI N/A
- ACLX N/A
- Industry
- NHI Real Estate Investment Trusts
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- NHI Real Estate
- ACLX Health Care
- Exchange
- NHI Nasdaq
- ACLX Nasdaq
- Market Cap
- NHI 3.7B
- ACLX 4.4B
- IPO Year
- NHI 1991
- ACLX 2022
- Fundamental
- Price
- NHI $78.48
- ACLX $85.07
- Analyst Decision
- NHI Buy
- ACLX Strong Buy
- Analyst Count
- NHI 4
- ACLX 12
- Target Price
- NHI $82.75
- ACLX $114.75
- AVG Volume (30 Days)
- NHI 216.1K
- ACLX 488.6K
- Earning Date
- NHI 11-04-2025
- ACLX 11-06-2025
- Dividend Yield
- NHI 4.69%
- ACLX N/A
- EPS Growth
- NHI 6.78
- ACLX N/A
- EPS
- NHI 3.14
- ACLX N/A
- Revenue
- NHI $350,596,000.00
- ACLX $56,979,000.00
- Revenue This Year
- NHI $5.62
- ACLX N/A
- Revenue Next Year
- NHI $10.34
- ACLX $210.71
- P/E Ratio
- NHI $25.02
- ACLX N/A
- Revenue Growth
- NHI 7.21
- ACLX N/A
- 52 Week Low
- NHI $65.13
- ACLX $47.86
- 52 Week High
- NHI $82.32
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- NHI 51.42
- ACLX 72.85
- Support Level
- NHI $77.86
- ACLX $76.63
- Resistance Level
- NHI $80.35
- ACLX $83.45
- Average True Range (ATR)
- NHI 1.54
- ACLX 2.75
- MACD
- NHI -0.21
- ACLX 0.48
- Stochastic Oscillator
- NHI 38.28
- ACLX 90.06
About NHI National Health Investors Inc.
National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.